Cannabis Stocks

92.20k followers • 22 symbols Watchlist by Yahoo Finance

Follow this list to discover and track the stock of publicly traded companies with exposure to cannabis

Yahoo Finance
'We vape. We vote': Pro-vaping groups protest flavor ban
E-cigarette activists take to the streets of Washington DC to protest a proposed flavor ban.
Reuters
Tilray reports bigger loss as oversupply hits weed prices
Zacks
Trump Trade, Walmart & Nvidia Previews & Buy CASY Stock - Free Lunch
All eyes will be on President Trump Tuesday for U.S.-China trade war updates. Walmart, Nvidia, and others are set to report their quarterly earnings. And why Casey's General Stores (CASY) is a Zacks Rank 1 (Strong Buy) right now...
Zacks
AB InBev's Craft Brew Buyout to Boost Craft Beer Portfolio
AB InBev (BUD) agrees to buy the remaining stake in Craft Brew for $16.50 per share. The buyout is likely to strengthen AB InBev's position in the craft beer space.
Zacks
Can European Buyouts Aid Canopy Growth's (CGC) Q2 Earnings?
Canopy Growth (CGC) acquires a number of European companies to expand its production base across a region that promises great opportunities.
Zacks
Cronos Group (CRON) Reports Q3 Loss, Lags Revenue Estimates
Cronos (CRON) delivered earnings and revenue surprises of 33.33% and -3.05%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Zacks
What's in Store for Helmerich & Payne (HP) in Q4 Earnings?
Helmerich & Payne's (HP) much popular technologically-advanced FlexRigs with strong daily rate margins might reflect on segmental profits in the to-be-reported results.
Zacks
Globus Medical's U.S. Spine Arm Grows, Product Launches Aid
Globus Medical (GMED) is on course to commercially market ExcelsiusGPS platform and launch its spine deformity solution in early fourth quarter.
Zacks
Hologic's Aptima Genitalium Assay Gets Clinically Verified
This study result is expected to be a major stride forward in Hologic's (HOLX) commitment toward strengthening its Diagnostic Solutions business.
Associated Press
Cronos: 3Q Earnings Snapshot
Zacks
The Zacks Analyst Blog Highlights: Toyota, Netflix, AbbVie, Gilead and Fiserv
The Zacks Analyst Blog Highlights: Toyota, Netflix, AbbVie, Gilead and Fiserv
Zacks
What's in the Cards for Aurora Cannabis (ACB) in Q1 Earnings?
Aurora Cannabis' (ACB) Q1 earnings are likely to reflect cannabis revenue growth and improved gross margin.
Zacks
Medtronic (MDT) Releases Positive Study Results on Pacemaker
Medtronic (MDT) presents favorable results from study on leadless pacemaker, indicating potential for improving cardiac functions in patients having blockages.
Reuters
Pot company Cronos Group misses revenue estimates, hit by over supply
The cannabis industry in the country is facing a supply glut as companies ramp up production. Total operating expenses rose nearly five fold to C$34.8 million, driven by a surge in general and administrative expenses. Cronos said cannabis sales rose six fold to 3,142 kilograms outside the United States, primarily driven by increased cannabis production.
Investing.com
AbbVie Rises 3%
Investing.com - AbbVie (NYSE:ABBV) rose by 3.02% to trade at $88.25 by 11:54 (16:54 GMT) on Tuesday on the NYSE exchange.
Investing.com
Stocks - Linde, Walt Disney Rise Premarket; Tyson Foods Slumps
Investing.com - Stocks in focus in premarket trading on Tuesday:
Financial Times
AbbVie readies $27bn bond sale to finance Allergan takeover
Pharmaceutical company AbbVie prepared to sell one of the largest US corporate bond deals on record on Tuesday, as the company seeks to finance its takeover of former-rival Allergan. AbbVie is looking to borrow in the region of $27bn, according to people familiar with investor conversations. At that size, it will be the same size as Comcast’s $27bn bond sale in October 2018, to become the joint-fourth largest deal ever.
Zacks
5 Trendy Earnings Charts
Are cannabis and solar stocks still the place to be for traders in 2019?
Reuters
Anheuser-Busch to buy out Craft Brew Alliance in $321 million deal
Shares of Craft Brew Alliance soared 122.6% to $16.32 after the bell, hovering near the offer price of $16.50 in cash. The deal is a reversal in stance by the world's largest brewer, which owns 31.2% stake in Craft Brew and had said in August it would not buy out the company. Craft Brew's portfolio of regional breweries and lifestyle brands is an addition to Anheuser-Busch and will help fuel the growth of craft beer category in the competitive beer industry in the United States, Anheuser-Busch said.
Zacks
Top Research Reports for Toyota, Netflix & AbbVie
Top Research Reports for Toyota, Netflix & AbbVie
Investing.com
Day Ahead: Top 3 Things to Watch
Investing.com - Here is a preview of the top 3 things that could rock markets tomorrow.
Zacks
Can Cannabis Therapy Drive Canopy Growth's (CGC) Q2 Earnings?
A series of acquisitions is expected to have significantly contributed to Canopy Growth's (CGC) top line in the fiscal second quarter.
Zacks
Chegg, C.H. Robinson Worldwide, Tilray, Anheuser-Busch InBev and Novartis highlighted as Zacks Bull and Bear of the Day
Chegg, C.H. Robinson Worldwide, Tilray, Anheuser-Busch InBev and Novartis highlighted as Zacks Bull and Bear of the Day
Zacks
CVS Health's Aetna Prospects Solid, Omnicare Sluggish
CVS Health's (CVS) strong Pharmacy Services segment sales gain traction from growth in specialty services.
Zacks
New Age Beverages (NBEV) to Post Q3 Earnings: What to Expect?
New Age Beverages' (NBEV) third-quarter 2019 results might reflect gains from buyouts and a robust brand portfolio. However, higher costs might remain deterrents.